MELISSA O'NEILL: Open Payments
NPI 1265543870 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 12 payments from 7 companies in 2025. Trend: 2023 $495 · 2024 $336 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| ANI Pharmaceuticals, Inc. | 3 | $56 |
| Amgen Inc. | 2 | $28 |
| Genentech USA, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Sandoz Inc. | 1 | $16 |
Products named: PURIFIED CORTROPHIN GEL, SKYRIZI, TAVNEOS, RINVOQ, Actemra, COSENTYX, ACTHAR, HYRIMOZ.
Industry payments across NE — which companies pay providers there.
